Webinar: Agitation in Alzheimer’s Disease
Date: Aug 4, 2026 07:00 PM ET
This program explores the prevalence, impact, and symptoms of agitation associated with dementia due to Alzheimer’s disease, specifically focusing on residents living in a long-term care setting. Participants will review the current clinical care landscape for treatment of agitation associated with dementia due to Alzheimer’s disease. The program will also provide an overview of the Centers for Medicare & Medicaid Services Regulations on Antipsychotics.
We are thrilled to celebrate the exceptional individuals who have earned the honor of being named GAPNA's Rising Stars. These outstanding professionals have been selected by our board for their unwavering passion and dedication to advancing GAPNA's mission — promoting excellence in advanced practice nursing to enhance the well-being of older adults.